Nektar Therapeutics (NKTR) Other financing activities (2013 - 2026)

Nektar Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at $25000.0 for Q1 2026.

• In Q1 2026, Other financing activities changed N/A year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $7.9 million (changed N/A YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
• Other financing activities was $25000.0 for Q1 2026 at Nektar Therapeutics, down from $7.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.8 million in Q3 2025 to a low of $25000.0 in Q1 2026.
• Historically, Other financing activities has averaged $2.9 million across 3 years, with a median of $750000.0 in 2022.
• Biggest YoY gain for Other financing activities was 0.0% in 2022; the steepest drop was 0.0% in 2022.
• A 3-year view of Other financing activities shows it stood at $750000.0 in 2022, then jumped by 945.33% to $7.8 million in 2025, then slumped by 99.68% to $25000.0 in 2026.
• The last three Other financing activities figures came in at $25000.0 (Q1 2026), $7.8 million (Q3 2025), and $750000.0 (Q1 2022), per Business Quant data.